Luis A. Macias, PhD (Mass Spectrometry Scientist, Verve Therapeutics)

On-Demand
The advancement of CRISPR-based gene editing tools into biotherapeutics offers the potential for cures to genetic disorders and for new treatment paradigms for even common diseases. Arguably,...